Open access
Oct 2026
Preparing for Next-Generation Vaccines: Breakthrough Invasive Pneumococcal Disease Patterns Post-PCV13 and Post-PPSV23 in Australia.
Serotype 3, included in all current conjugate formulations, dominated breakthrough for both vaccines, and in descriptive comparisons limited by small subgroup sizes, neither additional doses nor sequential vaccination was associated with lower vaccine-type proportions.
Shayan Sharifi, S. Pelton, Inci Yildirim et al.
· International Journal of Inf... · 0 citations